BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10323455)

  • 1. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5.
    Gómez-Reino JJ; Pablos JL; Carreira PE; Santiago B; Serrano L; Vicario JL; Balsa A; Figueroa M; de Juan MD
    Arthritis Rheum; 1999 May; 42(5):989-92. PubMed ID: 10323455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of C-C chemokine receptor 5 Δ32 deletion status with rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, and disease severity.
    Martens HA; Gross S; van der Steege G; Brouwer E; Berden JH; de Sevaux R; Derksen RH; Voskuyl AE; Berger SP; Navis GJ; Kallenberg CG; Bijl M
    J Rheumatol; 2010 Nov; 37(11):2226-31. PubMed ID: 20682662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
    Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
    J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for negative association of the chemokine receptor CCR5 d32 polymorphism with rheumatoid arthritis.
    Pokorny V; McQueen F; Yeoman S; Merriman M; Merriman A; Harrison A; Highton J; McLean L
    Ann Rheum Dis; 2005 Mar; 64(3):487-90. PubMed ID: 15331395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients.
    Kohem CL; Brenol JC; Xavier RM; Bredemeier M; Brenol CV; Dedavid e Silva TL; de Castilhos Mello A; Cañedo AD; Neves AG; Chies JA
    Scand J Rheumatol; 2007; 36(5):359-64. PubMed ID: 17963165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis.
    Lindner E; Nordang GB; Melum E; Flatø B; Selvaag AM; Thorsby E; Kvien TK; Førre OT; Lie BA
    BMC Med Genet; 2007 Jun; 8():33. PubMed ID: 17565662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.
    Lo SF; Wan L; Lin HC; Huang CM; Tsai FJ
    J Rheumatol; 2008 Nov; 35(11):2113-8. PubMed ID: 19004052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
    Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA
    Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus.
    Aguilar F; Núñez-Roldán A; Torres B; Wichmann I; Sánchez-Román J; González-Escribano MF
    J Rheumatol; 2003 Aug; 30(8):1770-4. PubMed ID: 12913933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential CCR5Delta32 allelic frequencies in juvenile idiopathic arthritis subtypes: evidence for different regulatory roles of CCR5 in rheumatological diseases.
    Scheibel I; Veit T; Neves AG; Souza L; Prezzi S; Machado S; Kohem C; Icarelli M; Xavier R; Brenol JC; Chies JA
    Scand J Rheumatol; 2008; 37(1):13-7. PubMed ID: 18189189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus.
    Orozco G; Sánchez E; González-Gay MA; López-Nevot MA; Torres B; Cáliz R; Ortego-Centeno N; Jiménez-Alonso J; Pascual-Salcedo D; Balsa A; de Pablo R; Nuñez-Roldan A; González-Escribano MF; Martín J
    Arthritis Rheum; 2005 Jan; 52(1):219-24. PubMed ID: 15641066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
    Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
    Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis.
    Zapico I; Coto E; Rodríguez A; Alvarez C; Torre JC; Alvarez V
    Genes Immun; 2000; 1(4):288-9. PubMed ID: 11196706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Prahalad S
    Genes Immun; 2006 Apr; 7(3):264-8. PubMed ID: 16541097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The delta32 deletion of CCR5 receptor in rheumatoid arthritis.
    Cooke SP; Forrest G; Venables PJ; Hajeer A
    Arthritis Rheum; 1998 Jun; 41(6):1135-6. PubMed ID: 9627027
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
    Sandford B; Bown M; London N; Sayers R
    Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus.
    Lin SC; Yen JH; Tsai JJ; Tsai WC; Ou TT; Liu HW; Chen CJ
    Arthritis Rheum; 2004 Mar; 50(3):770-5. PubMed ID: 15022318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas promoter -670 polymorphism is associated with development of anti-RNP antibodies in systemic lupus erythematosus.
    Lee YH; Kim YR; Ji JD; Sohn J; Song GG
    J Rheumatol; 2001 Sep; 28(9):2008-11. PubMed ID: 11550967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.